Kadimastem Ltd (TLV:KDST)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,939.00
0.00 (0.00%)
Feb 20, 2025, 2:02 PM IDT
231.45%
Market Cap 81.36M
Revenue (ttm) n/a
Net Income (ttm) -9.72M
Shares Out 4.19M
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 550
Average Volume 8,778
Open 1,939.00
Previous Close 1,939.00
Day's Range 1,900.00 - 1,950.00
52-Week Range 430.00 - 1,979.00
Beta 0.28
RSI 68.02
Earnings Date Mar 27, 2025

About Kadimastem

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 12
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol KDST
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.